PNT
Price:
$12.5
Market Cap:
$1.33B
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of neuroendocrine tumors. The company is also developing PNT2001, a next-generation PSMA-targeting product candidate for the treatment of non-metastatic castration sensitive prostate cancer, which is under preclinical studies; and PNT-2004, a fibroblast...[Read more]
Industry
Biotechnology
IPO Date
2020-07-08
Stock Exchange
NASDAQ
Ticker
PNT
According to POINT Biopharma Global Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of POINT Biopharma Global Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), PNT's Dividend Yield was at its highest in in the April 2020 quarter at 0%. The Dividend Yield was at its lowest in in the April 2020 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of POINT Biopharma Global Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
The current Dividend Yield of POINT Biopharma Global Inc. (PNT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
POINT Biopharma Global Inc.’s Dividend Yield is less than ORIC Pharmaceuticals, Inc. (0%), less than Lyra Therapeutics, Inc. (0%), less than Inhibrx Biosciences, Inc. (5.87%), less than ESSA Pharma Inc. (0%), less than Crinetics Pharmaceuticals, Inc. (0%), less than ALX Oncology Holdings Inc. (0%), less than Immatics N.V. (0%), less than BioAtla, Inc. (0%), less than Aerovate Therapeutics, Inc. (0%), less than Cerevel Therapeutics Holdings, Inc. (0%), less than RAPT Therapeutics, Inc. (0%), less than Cyteir Therapeutics, Inc. (0%), less than Pardes Biosciences, Inc. (0%), less than Third Harmonic Bio, Inc. (0%), less than PMV Pharmaceuticals, Inc. (0%), less than Edgewise Therapeutics, Inc. (0%), less than Enochian Biosciences, Inc. (0%), less than Revolution Medicines, Inc. (0%), less than NewAmsterdam Pharma Company N.V. (0%), less than Centessa Pharmaceuticals plc (0%), less than Sutro Biopharma, Inc. (0%), less than Opthea Limited (0%), less than HilleVax, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $577.94M | |
0% | $11.28M | |
5.87% | $209.76M | |
0% | $71.43M | |
0% | $5.00B | |
0% | $96.52M | |
0% | $847.43M | |
0% | $30.00M | |
0% | $75.07M | |
0% | $8.19B | |
0% | $60.48M | |
0% | $108.71M | |
0% | $135.19M | |
0% | $465.00M | |
0% | $76.07M | |
0% | $2.80B | |
0% | $45.38M | |
0% | $8.09B | |
0% | $2.94B | |
0% | $2.23B | |
0% | $159.15M | |
0% | $4.47B | |
0% | $93.14M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like POINT Biopharma Global Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like POINT Biopharma Global Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is POINT Biopharma Global Inc.'s Dividend Yield?
How is the Dividend Yield calculated for POINT Biopharma Global Inc. (PNT)?
What is the highest Dividend Yield for POINT Biopharma Global Inc. (PNT)?
What is the 3-year average Dividend Yield for POINT Biopharma Global Inc. (PNT)?
What is the 5-year average Dividend Yield for POINT Biopharma Global Inc. (PNT)?
How does the current Dividend Yield for POINT Biopharma Global Inc. (PNT) compare to its historical average?